Advanced search
Publication Cover
Current Medical Research and Opinion Volume 24, 2008 - Issue 3
Submit an article Journal homepage
148
Views
12
CrossRef citations to date
0
Altmetric
Original Article

Relationship between bone mass, invasive breast cancer incidence and raloxifene therapy in postmenopausal women with low bone mass or osteoporosis

Alan L. Burshell Ochsner Clinic Foundation, New Orleans, LA, USACorrespondence[email protected]
,
Jingli Song Eli Lilly and Company, Indianapolis, IN, USA
,
Sherie A. Dowsett Eli Lilly and Company, Indianapolis, IN, USA
,
John L. Mershon Eli Lilly and Company, Indianapolis, IN, USA
,
Pierre D. Delmas University Claude Bernard Lyon 1 and INSERM Research Unit 831, Hôpital Edouard Herriot, Lyon, France
,
Roberta J. Secrest Eli Lilly and Company, Indianapolis, IN, USA
&
Jane A. Cauley University of Pittsburgh, Pittsburgh, PA, USA
 show all
Pages 807-813 | Accepted 09 Jan 2008, Published online: 05 Feb 2008

Citations (12)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Jian-Hua Chen, Quan Yuan, Ya-Nan Ma, Shi-Han Zhen & De-Liang Wen. (2019) Relationship between bone mineral density and the risk of breast cancer: a systematic review and dose–response meta-analysis of ten cohort studies. Cancer Management and Research 11, pages 1453-1464.
Read now
Enrico M Messalli & Cono Scaffa. (2009) Long-term safety and efficacy of raloxifene in the prevention and treatment of postmenopausal osteoporosis: an update. International Journal of Women's Health 1, pages 11-20.
Read now

Articles from other publishers (10)

Daniel Halloran, Hilary W. Durbano & Anja Nohe. (2020) Bone Morphogenetic Protein-2 in Development and Bone Homeostasis. Journal of Developmental Biology 8:3, pages 19.
Crossref
Wolfgang BrozekGabriele NagelHanno UlmerHans Concin. (2019) Bone Mineral Density and Breast Cancer Incidence and Mortality in Postmenopausal Women: A Long-Term Follow-Up Study. Journal of Women's Health 28:5, pages 628-635.
Crossref
G. Nagel, R.S. Peter, E. Klotz, W. Brozek & H. Concin. (2017) Bone mineral density and breast cancer risk: Results from the Vorarlberg Health Monitoring & Prevention Program and meta-analysis. Bone Reports 7, pages 83-89.
Crossref
Berna Seckin, Meryem Kuru Pekcan, Hasan Ali Inal & Cavidan Gulerman. (2016) The relationship between breast density and bone mineral density in never users of postmenopausal hormone therapy. Aging Clinical and Experimental Research 29:3, pages 537-541.
Crossref
Kala VisvanathanPatricia HurleyElissa BantugPowel BrownNananda F. ColJack CuzickNancy E. DavidsonAndrea DeCensiCarol FabianLeslie FordJudy GarberMaria KatapodiBarnett KramerMonica MorrowBarbara ParkerCarolyn RunowiczVictor G. VogelIIIIIIJames L. WadeScott M. Lippman. (2013) Use of Pharmacologic Interventions for Breast Cancer Risk Reduction: American Society of Clinical Oncology Clinical Practice Guideline. Journal of Clinical Oncology 31:23, pages 2942-2962.
Crossref
Nigel J Bundred, Peter Kenemans, Cheng Har Yip, Matthias W Beckmann, Jean-Michel Foidart, Piero Sismondi, Bo von Schoultz, Rena Vassilopoulou-Sellin, Rachid El Galta, Eugenie Van Lieshout, Mirjam Mol-Arts, Juan Planellas & Ernst Kubista. (2012) Tibolone increases bone mineral density but also relapse in breast cancer survivors: LIBERATE trial bone substudy. Breast Cancer Research 14:1.
Crossref
Debjani Grenier, Andrew L. Cooke, Lisa Lix, Colleen Metge, Huimin Lu & William D. Leslie. (2010) Bone mineral density and risk of postmenopausal breast cancer. Breast Cancer Research and Treatment 126:3, pages 679-686.
Crossref
Peter Vestergaard, Lone Fischer, Marco Mele, Leif Mosekilde & Peer Christiansen. (2011) Use of Bisphosphonates and Risk of Breast Cancer. Calcified Tissue International 88:4, pages 255-262.
Crossref
J. Christopher Gallagher & Jeffrey P. Levine. (2011) Preventing osteoporosis in symptomatic postmenopausal women. Menopause 18:1, pages 109-118.
Crossref
Susen Becker & Rudolf Kaaks. 2009. Cancer Prevention II. Cancer Prevention II 135 157 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.